معرفی
Dr. Pingping Han is an NHMRC Emerging Leadership Fellow at the University of Queensland's School of Dentistry within the Faculty of Health, Medicine and Behavioural Sciences. She leads the Epigenetic Nanodiagnostics and Therapeutics Group at the Centre for Orofacial Regeneration, Reconstruction and Rehabilitation (COR3) and is affiliated with the Centre for Extracellular Vesicle Nanomedicine.
Dr. Han received her PhD in Biomedical Engineering from Queensland University of Technology in 2014. Her research spans multiple interdisciplinary fields including dentistry, nanomedicine, epigenetics, and tissue engineering.
Her primary research interests focus on three key areas: salivary diagnostics for periodontal disease, cell-free regenerative therapy for periodontal tissue engineering, and cellular nano-mechanics on modified biomaterial substrates. She has published extensively on extracellular vesicles, particularly their role in periodontal disease diagnosis and therapy, with over 77 publications including numerous high-impact journal articles.
Analysis of her recent publications reveals a strong focus on extracellular vesicles as diagnostic and therapeutic tools, 3D bioprinting technologies for dental applications, and the molecular mechanisms underlying periodontal disease. Her work bridges basic science with clinical applications, particularly in developing novel diagnostic approaches using salivary biomarkers and exploring cell-free regenerative therapies.
- NHMRC Emerging Leadership Fellowship
Dr. Han actively supervises multiple PhD and Master's students, with current projects focusing on periodontal cell-derived extracellular vesicles, nano-diagnostics, cellular nano-mechanics, and omics in dentistry. She has secured significant research funding from organizations including NHMRC, International Team for Implantology Foundation, and Osteology Foundation for projects related to extracellular vesicles and periodontal regeneration.
She leads research initiatives at the intersection of dentistry, nanotechnology, and molecular biology, particularly through her Epigenetic Nanodiagnostics and Therapeutics Group which explores innovative approaches to periodontal disease diagnosis and treatment.
